https://www.marketscreener.com/quote/stock/CORCEPT-THERAPEUTICS-INCO-40449488/news/Corcept-Therapeutics-Incorporated-Completes-Enrollment-in-Pivotal-Phase-3-Rosella-Trial-of-Relacoril-46398856/?utm_source=telegram&utm_medium=social&utm_campaign=share